Company Information

Learn More About XBRL  

Address: 6 CEDAR BROOK DRIVE  
City: CRANBURY 
State: NJ 
Zip Code: 08512 
Telephone: (609) 662-2000 


Description of Business


Primary SIC Code: 2834
(As filed with the SEC)  

We are a biopharmaceutical company focused on the discovery, development and commercialization of orally-administered, small molecule drugs known as pharmacological chaperones. Pharmacological chaperones are a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and diseases of neurodegeneration. Our goal is to become a leading biopharmaceutical company in these areas. Our current strategic priorities include the following: . Phase 3 development of our lead product candidate, Amigal for Fabry disease; . preclinical and clinical development of combination therapy involving pharmacological chaperones and enzyme replacement therapy; and . preclinical evaluation of the use of pharmacological chaperones for diseases of neurodegeneration.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2010-0.08NAN/E
03/2010-0.30NAN/E
12/2009-0.29NAN/E
09/2009-2.38NAN/E
06/2009-2.14NAN/E
03/2009-1.96NAN/E
12/2008-1.75NAN/E
09/2008-1.34NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2009 Leverage 2009
Net Inc/Comm Equity-0.03Total Liab/Total Assets0.16
Net Inc/Total Assets-0.08Total Liab/Inv Cap0.19
Net Inc/Inv Cap-0.09Total Liab/Comm Equity0.06
Pretax Inc/Net Sales-0.10Interest Coverage Ratio-22.62
Net Inc/Net Sales-0.10Curr Debt/Equity0.02
Cash Flow/Net Sales-0.67LTD/Equity0.03
SG&A/NetSales0.31Total Debt/Equity0.05
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio7.19
Inventory TurnoverNACurrent Ratio7.19
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work Cap0.93Inv/Curr AssetsNA
Net Sales/PP&E14.63  

Income Statement (Millions)

  6/30/2010 3/31/2010 12/31/2009 9/30/2009
Total Revenues(Net Sales) 0.00 0.00 49.48 4.91
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 4.02 3.93 4.34 5.22
Operating Income -12.69 -13.35 32.94 -13.47
Interest Exp 0.05 0.08 0.12 0.08
Pretax Income -11.32 -13.18 32.96 -13.43
Other Income 1.43 0.26 0.14 0.13
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -11.32 -13.18 32.96 -13.43

Balance Sheet (Millions)

Assets 6/30/2010 3/31/2010 12/31/2009 9/30/2009
Cash & Short Term Investments 69.07 81.43 78.22 89.27
Receivables - Total NA NA NA NA
Inventories - Total NA NA NA NA
Total Current Assets 71.15 83.94 80.49 93.58
Net Property, Plant & Equipment 3.47 3.93 4.40 5.05
Total Assets 74.89 88.14 85.37 98.89
Liabilities        
Accounts Payable 5.75 7.36 9.64 12.76
Debt in Current Liabilities 1.40 1.48 1.56 1.55
Total Current Liabilities 7.15 8.84 11.19 17.08
Long-Term Debt 1.67 5.11 2.34 2.70
Total Liabilities 10.52 13.94 13.54 61.73
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.34 0.34 0.29 0.29
Retained Earnings -195.25 -183.93 -170.76 -203.71
Treasury Stock NA NA NA NA
Total Stockholders' Equity 64.36 74.19 71.83 37.16
Total Liabilities and Stockholders' Equity 74.89 88.14 85.37 98.89

Cash Flow Summary (Millions)

Categories 6/30/2010 3/31/2010 12/31/2009 9/30/2009
Net Cash Provided by Operating Activities -11.86 -13.43 -10.59 -11.47
Net Cash Provided by Investing Activities 3.36 10.90 9.77 15.54
Net Cash Provided by Financing Activities -0.45 16.75 -0.33 0.66

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20050.00-19.97--
12/20060.00-46.34--
12/20071.78-41.17-3.14
12/200814.97-39.35-1.75
12/200964.36-6.57-0.29
Growth RatesInfinity----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/105811,93843.20




Report Date : 8/30/2010

Powered By Edgar Online Copyright 2010, EDGAR Online, Inc. All rights reserved. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.